163 related articles for article (PubMed ID: 21599760)
1. Editorial comment to erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib.
Wu Y; Zhao Y
Int J Urol; 2011 Jun; 18(6):430-1. PubMed ID: 21599760
[No Abstract] [Full Text] [Related]
2. Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib.
Zhang HL; Zhu Y; Wang CF; Yao XD; Zhang SL; Dai B; Shen YJ; Zhu YP; Shi GH; Ye DW
Int J Urol; 2011 Jun; 18(6):422-30. PubMed ID: 21481012
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment to Treatment outcomes of sorafenib for first line or cytokine-refractory advanced renal cell carcinoma in Japanese patients.
Tomita Y
Int J Urol; 2010 Sep; 17(9):815-6. PubMed ID: 20727052
[No Abstract] [Full Text] [Related]
4. Sorafenib rechalenge in metastatic renal cell carcinoma.
Porta C; Paglino C; Imarisio I
BJU Int; 2012 Sep; 110(6 Pt B):E235. PubMed ID: 22332769
[No Abstract] [Full Text] [Related]
5. Editorial comment.
Rini BI; Shah SN
Urology; 2010 May; 75(5):1114-5; author reply 1115. PubMed ID: 20451727
[No Abstract] [Full Text] [Related]
6. Editorial comment.
Vaishampayan U
Urology; 2010 May; 75(5):1114; author reply 1115. PubMed ID: 20451726
[No Abstract] [Full Text] [Related]
7. Characterization of tumor specimens for a targeted therapy in metastatic renal cell carcinoma patients.
Raspollini MR
Curr Oncol Rep; 2007 Sep; 9(5):331. PubMed ID: 17706159
[No Abstract] [Full Text] [Related]
8. CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.
Stein MN; Flaherty KT
Clin Cancer Res; 2007 Jul; 13(13):3765-70. PubMed ID: 17606705
[No Abstract] [Full Text] [Related]
9. Sorafenib in metastatic renal cell carcinoma with sarcomatoid differentiation.
Lekili M; Muezzinoglu T; Nese N; Temeltas G
J Chin Med Assoc; 2010 May; 73(5):262-4. PubMed ID: 20685594
[TBL] [Abstract][Full Text] [Related]
10. Targeting renal cell carcinoma.
Motzer RJ; Molina AM
J Clin Oncol; 2009 Jul; 27(20):3274-6. PubMed ID: 19451422
[No Abstract] [Full Text] [Related]
11. Sorafenib [corrected] in kidney cancer.
Escudier B
Ann Oncol; 2007 Jul; 18 Suppl 9():ix90-3. PubMed ID: 17631603
[No Abstract] [Full Text] [Related]
12. Health policy: The UK 'postcode lottery' in renal cell carcinoma.
Larkin J; Gore M
Nat Rev Urol; 2009 Dec; 6(12):636-8. PubMed ID: 19956190
[No Abstract] [Full Text] [Related]
13. [Renal cell carcinoma].
Oya M
Gan To Kagaku Ryoho; 2010 Jan; 37(1):29-31. PubMed ID: 20140991
[No Abstract] [Full Text] [Related]
14. Tilting the AXIS towards therapeutic limits in renal cancer.
Bex A; Haanen J
Lancet; 2011 Dec; 378(9807):1898-900. PubMed ID: 22056245
[No Abstract] [Full Text] [Related]
15. Recent advances in molecular targeted therapy for metastatic renal cell carcinoma.
Mizutani Y
Int J Urol; 2009 May; 16(5):444-8. PubMed ID: 19298634
[TBL] [Abstract][Full Text] [Related]
16. Two new drugs for renal cell carcinoma.
Med Lett Drugs Ther; 2007 Feb; 49(1255):18-20. PubMed ID: 17325624
[No Abstract] [Full Text] [Related]
17. Is it possible to optimize the use of targeted therapies in the treatment of renal cell carcinoma?
Procopio G; Verzoni E; Guadalupi V; Iacovelli R; Bajetta E
Tumori; 2010; 96(5):794-5. PubMed ID: 21302633
[No Abstract] [Full Text] [Related]
18. Randomized discontinuation trial of sorafenib (BAY 43-9006).
Jain L; Venitz J; Figg WD
Cancer Biol Ther; 2006 Oct; 5(10):1270-2. PubMed ID: 16969070
[TBL] [Abstract][Full Text] [Related]
19. Sustained response following sorafenib therapy in an older adult patient with advanced renal cancer on hemodialysis: a case report.
Castagneto B; Stevani I; Giorcelli L; Montefiore F; Bigatti GL; Pisacco P; Cosimi MF
Med Oncol; 2011 Dec; 28(4):1384-8. PubMed ID: 20552299
[TBL] [Abstract][Full Text] [Related]
20. [Sorafenib(Nexavar)].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 2009 Jun; 36(6):1029-33. PubMed ID: 19542731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
